Mesenchymal Stromal Cells, Instigator or Suppressor for the Development of MLL-AF9 Induced Acute Myeloid Leukemia?

被引：0
|
作者：
Xiao, Pingnan [1 ]
Heshmati, Yaser [2 ]
Bouderlique, Thibault [2 ]
Kondo, Makoto [2 ]
Dolinska, Monika [1 ]
Sandhow, Lakshmi [1 ]
Johansson, Anne-Sofie [1 ]
Walfridsson, Julian [2 ]
Qian, Hong [1 ]
机构：
[1] Karolinska Inst, Dept Med, Ctr Hematol & Regenerat Med HERM, Stockholm, Sweden
[2] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Ctr Hematol & Regenerat Med HERM, Stockholm, Sweden
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.1488.1488
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1488
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Establishing Human Niche Xenograft Models For Myeloid and Lymphoid Leukemia Driven By MLL-AF9
    Carretta, Marco
    Jaques, Jennifer
    Yuan Huipin
    Martens, Anton
    Vellenga, Edo
    Groen, Richard
    Schuringa, Jan Jacob
    BLOOD, 2013, 122 (21)
  • [32] Intrinsic Disorder, Epigenetics, and Leukemia - the MLL-AF9 SAGA
    Bushweller, John
    Kuntimaddi, Aravinda
    Thorpe, Jeremy
    Achille, Nicholas
    Lokken, Alyson
    Singh, Ritambhara
    Adli, Mazhar
    Zeleznik-Le, Nancy
    BIOPHYSICAL JOURNAL, 2015, 108 (02) : 5A - 5A
  • [33] ABNORMAL INTRAGENIC TRANSCRIPTIONAL ACTIVATION IN MLL-AF9 AND KAT6A-CREBBP ACUTE MYELOID LEUKEMIA (AML)
    Marneth, A. E.
    Prange, K.
    Bergevoet, S. M.
    Obulkasim, A.
    Zwaan, C. M.
    Van den Heuvel-Eibrink, M. M.
    Haferlach, T.
    Fornerod, M.
    Jansen, J. H.
    Martens, J.
    Van der Reijden, B. A.
    HAEMATOLOGICA, 2016, 101 : 36 - 37
  • [34] Integrated transcriptomic and epigenetic data analysis identifiesaberrant expression of genes in acute myeloid leukemia with MLL-AF9 translocation
    Wang, Fangce
    Li, Zheng
    Wang, Guangming
    Tian, Xiaoxue
    Zhou, Jie
    Yu, Wenlei
    Fan, Zhuoyi
    Dong, Lin
    Lu, Jinyuan
    Xu, Jun
    Zhang, Wenjun
    Liang, Aibin
    MOLECULAR MEDICINE REPORTS, 2020, 21 (02) : 883 - 893
  • [35] A CASE OF MLL-AF9 REARRANGED ACUTE MONOCYTIC LEUKEMIA WITH MARKED BILATERAL NEPHROMEGALY
    Mitani, Kazuki
    Fujino, Hisanori
    Okada, Hidenori
    Shiraishi, Kei
    Harada, Taro
    Obu, Satoshi
    Nomura, Anryu
    Sumimoto, Shinichi
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [36] P2X7 promotes the progression of MLL-AF9 induced acute myeloid leukemia by upregulation of Pbx3
    Feng, Wenli
    Yang, Xiao
    Wang, Lina
    Wang, Rong
    Yang, Feifei
    Wang, Hao
    Liu, Xiaoli
    Ren, Qian
    Zhang, Yingchi
    Zhu, Xiaofan
    Zheng, Guoguang
    HAEMATOLOGICA, 2021, 106 (05) : 1278 - 1289
  • [37] MLL-AF9 leukemia stem cells: Hardwired or taking cues from the microenvironment?
    Muntean, Andrew G.
    Hess, Jay L.
    CANCER CELL, 2008, 13 (06) : 465 - 467
  • [38] Continued expression of the NRAS(G12V) oncogene is required for the maintenance of acute myeloid leukemia induced in cooperation with MLL-AF9
    Kim, Won-Il
    Matise, Ilze
    Diers, Miechaleen
    Largaespada, David
    BLOOD, 2007, 110 (11) : 482A - 482A
  • [39] C-terminal BRE inhibits cellular proliferation and increases sensitivity to chemotherapeutic drugs of MLL-AF9 acute myeloid leukemia cells
    Pun, Charmaine Cheuk-Man
    Lee, Kenneth Ka-Ho
    Chui, Yiu-Loon
    LEUKEMIA & LYMPHOMA, 2019, 60 (12) : 3011 - 3019
  • [40] Gaq signaling is required for the maintenance of MLL-AF9-induced acute myeloid leukemia
    Lynch, J. R.
    Yi, H.
    Casolari, D. A.
    Voli, F.
    Gonzales-Aloy, E.
    Fung, T. K.
    Liu, B.
    Brown, A.
    Liu, T.
    Haber, M.
    Norris, M. D.
    Lewis, I. D.
    So, C. W. E.
    D'Andrea, R. J.
    Wang, J. Y.
    LEUKEMIA, 2016, 30 (08) : 1745 - 1748
12345